HPV16 E7 TRANSGENIC SKIN IS NOT REJECTED IN E7 IMMUNIZED MICE

被引:0
|
作者
FRAZER, IH
DUNN, LA
FERNANDO, GJP
TINDLE, RW
LEIPPE, DM
LAMBERT, PF
机构
[1] UNIV QUEENSLAND,PRINCESS ALEXANDRA HOSP,PAPILLOMAVIRUS RES UNIT,ST LUCIA,QLD 4067,AUSTRALIA
[2] UNIV WISCONSIN,SCH MED,MCARDLE LAB CANC RES,MADISON,WI 53706
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:310 / 310
页数:1
相关论文
共 50 条
  • [41] The Heterogeneous Structural Behavior of E7 from HPV16 Revealed by NMR Spectroscopy
    Calcada, Eduardo O.
    Felli, Isabella C.
    Hosek, Tomas
    Pierattelli, Roberta
    CHEMBIOCHEM, 2013, 14 (14) : 1876 - 1882
  • [42] Photosensitizer-induced HPV16 E7 nanovaccines for cervical cancer immunotherapy
    Zhang, Liming
    Wang, Kun
    Huang, Yuheng
    Zhang, Hui
    Zhou, Long
    Li, Ang
    Sun, Yunyan
    BIOMATERIALS, 2022, 282
  • [43] HPV16 E7 CTL Epitope Antigen Peptide Design and Activity Evaluation
    Wang Juan
    Shu Mao
    Lin Yong
    Hu Yong
    Han Ying-Zi
    Lin Zhi-Hua
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2015, 42 (12) : 1119 - 1127
  • [44] Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes
    Carraresi, L
    Tripodi, SA
    Mulder, LCF
    Bertini, S
    Nuti, S
    Schuerfeld, K
    Cintorino, M
    Bensi, G
    Rossini, M
    Mora, M
    ONCOGENE, 2001, 20 (56) : 8148 - 8153
  • [45] Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes
    Laura Carraresi
    Sergio A Tripodi
    Lubbertus CF Mulder
    Sabrina Bertini
    Sandra Nuti
    Karin Schuerfeld
    Marcella Cintorino
    Giuliano Bensi
    Mara Rossini
    Marirosa Mora
    Oncogene, 2001, 20 : 8148 - 8153
  • [46] Mutation in the immunodominant epitope of the HPV16 E7 oncoprotein as a mechanism of tumor escape
    Michal Smahel
    Pavla Tejklova
    Jana Smahelova
    Ingrid Polakova
    Jana Mackova
    Cancer Immunology, Immunotherapy, 2008, 57
  • [47] P19ARF inhibits the functions of the HPV16 E7 oncoprotein
    Wei Pan
    Abhishek Datta
    Guy R Adami
    Pradip Raychaudhuri
    Srilata Bagchi
    Oncogene, 2003, 22 : 5496 - 5503
  • [48] IDENTIFICATION OF HPV-16 E7 PEPTIDES THAT ARE POTENT ANTAGONISTS OF E7 BINDING TO THE RETINOBLASTOMA SUPPRESSOR PROTEIN
    JONES, RE
    WEGRZYN, RJ
    PATRICK, DR
    BALISHIN, NL
    VUOCOLO, GA
    RIEMEN, MW
    DEFEOJONES, D
    GARSKY, VM
    HEIMBROOK, DC
    OLIFF, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (22) : 12782 - 12785
  • [49] Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors
    Li, Yan-Li
    Qiu, Xu-Hua
    Shen, Chen
    Liu, Jian-Ning
    Zhang, Jing
    ONCOLOGY REPORTS, 2010, 24 (05) : 1323 - 1329
  • [50] Ii-Key/HPV16 E7 hybrid peptide immunotherapy for HPV16+cancers
    Xu, Minzhen
    Lu, Xueqing
    Sposato, Margaret
    Zinckgraf, John W.
    Wu, Shuzhen
    von Hofe, Eric
    VACCINE, 2009, 27 (34) : 4641 - 4647